← FDA DRUG APPROVALS

FDA ANDA · ANDA084292

BUTABARBITAL SODIUM

Sponsor: SANDOZ

APPLICATION
ANDA084292
TYPE
ANDA
LATEST ACTION
1985-08-16
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

BUTABARBITAL SODIUMDiscontinued
BUTABARBITAL SODIUM 15MG · TABLET · ORAL

Approval history

1985-08-16Manufacturing (CMC) · Supplement 65AP
1984-06-05Manufacturing (CMC) · Supplement 62AP
1984-06-05Manufacturing (CMC) · Supplement 63AP
1983-07-21Manufacturing (CMC) · Supplement 60AP
1983-07-21Manufacturing (CMC) · Supplement 61AP
1983-06-03Manufacturing (CMC) · Supplement 57AP
1983-05-16Manufacturing (CMC) · Supplement 59AP
1983-03-30Manufacturing (CMC) · Supplement 55AP
1982-02-09Manufacturing (CMC) · Supplement 51AP
1982-02-09Manufacturing (CMC) · Supplement 52AP
1982-02-09Manufacturing (CMC) · Supplement 50AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →